Activity of cisplatin in adenocarcinoma of the pancreas

The activity of cisplatin in metastatic adenocarcinoma of the pancreas was assessed in 33 patients. Cisplatin was administered in a dose of 100 mg/m 2, every 4 weeks. There were 2 complete responses and 5 partial responses (a response rate of 21%). The median duration of response was 5 months (range...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of cancer (1990) 1993, Vol.29 (2), p.203-204
Hauptverfasser:	Wils, J.A., Kok, T., Wagener, D.J.Th, Selleslags, J., Duez, N.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma - drug therapy Adult Aged Cisplatin - therapeutic use Drug Administration Schedule Female Humans Liver Neoplasms - secondary Male Middle Aged Pancreatic Neoplasms - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!